Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Rowan

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Cancer Discovery|January 8, 2025
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Nature Ecology & Evolution|December 24, 2021
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal studyXiao Fu, Yue Zhao, Jose I Lopez, et al.
Genome Biology|August 28, 2014
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolutionRosalie Fisher, Stuart Horswell, Andrew Rowan, et al.
Nature|November 7, 2024
Origins and impact of extrachromosomal DNAChris Bailey, Oriol Pich, Kerstin Thol, et al.
Cancer Discovery|September 8, 2025
Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in GlioblastomaImran Noorani, Magnus Haughey, Jens Luebeck, et al.
Cancer Cell|July 4, 2025
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.
Cancer Cell|May 19, 2026
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.
Nature Communications|March 20, 2015
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolutionMichal Kovac, Carolina Navas, Stuart Horswell, et al.
Cell|April 17, 2018
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx RenalSamra Turajlic, Hang Xu, Kevin Litchfield, et al.
Nature|February 19, 2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressuresMaise Al Bakir, James L Reading, Samuel Gamble, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Cancer Discovery|January 8, 2025
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Nature Ecology & Evolution|December 24, 2021
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal studyXiao Fu, Yue Zhao, Jose I Lopez, et al.
Genome Biology|August 28, 2014
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolutionRosalie Fisher, Stuart Horswell, Andrew Rowan, et al.
Nature|November 7, 2024
Origins and impact of extrachromosomal DNAChris Bailey, Oriol Pich, Kerstin Thol, et al.
Cancer Discovery|September 8, 2025
Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in GlioblastomaImran Noorani, Magnus Haughey, Jens Luebeck, et al.
Cancer Cell|July 4, 2025
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.
Cancer Cell|May 19, 2026
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.
Nature Communications|March 20, 2015
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolutionMichal Kovac, Carolina Navas, Stuart Horswell, et al.
Cell|April 17, 2018
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx RenalSamra Turajlic, Hang Xu, Kevin Litchfield, et al.
Nature|February 19, 2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressuresMaise Al Bakir, James L Reading, Samuel Gamble, et al.
Pageof 9